Neurolief

📍 Netanya, Israel🗓 Founded 2014👥 28 employees💰 Last funded Apr 2017
Medical Equipment Manufacturing🌐 neurolief.com
Website LinkedIn
Neurolief develops proprietary digital theraputics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic head mounted devices designed to concurrently neuromodulate target major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. These devices are intended to provide a highly effective, side-effects free treatment for the hundreds of millions of patients worldwide. Neurolief is led by a seasoned team with extensive experience and successful track record developing multiple neuromodulation devices for patients with central nervous system deficiencies.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Neurolief?
Neurolief has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Neurolief last raise funding?
The most recent investment in Neurolief recorded on gritt.io was in April 2017.
When was Neurolief founded?
Neurolief was founded in 2014.
What industry is Neurolief in?
Neurolief operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Neurolief based?
Neurolief is headquartered in Netanya, Israel.